Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists
2019 · World Neurosurgery · 39 citations
https://doi.org/10.1016/j.wneu.2019.04.180
X
Xuan Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
321
Citations
8
h-index
8
i10-index
Xuan Liu is an academic researcher from Xinyang Normal University. The author has contributed to research in topics: RNA Interference and Gene Delivery & Virus-based gene therapy research & Cancer Research and Treatments. The author has an h-index of 8, co-authored 37 publications.
ORCID: 0009-0001-8219-6400Papers by this author
worksRole of N6-methyladenosine in tumor neovascularization
2024 · Cell Death and Disease · 14 citations
https://doi.org/10.1038/s41419-024-06931-z
Intracellular expression of arginine deiminase activates the mitochondrial apoptosis pathway by inhibiting cytosolic ferritin and inducing chromatin autophagy
2020 · BMC Cancer · 10 citations
https://doi.org/10.1186/s12885-020-07133-4
Fusion-Optimized Multimodal Entity Alignment with Textual Descriptions
2025 · Information · 1 citations
https://doi.org/10.3390/info16070534
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat